Olanzapine in the treatment of refractory migraine and chronic daily headache.
about
Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adultsNon-pharmacological interventions for somatoform disorders and medically-unexplained physical symptoms (MUPS) in adultsAntipsychotics for acute and chronic pain in adultsPharmacological interventions for somatoform disorders in adultsAntipsychotics for acute and chronic pain in adultsNeuroleptics in headache.A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Duliang Soft Capsule in Patients with Chronic Daily HeadacheOlanzapine Attenuates Mechanical Allodynia in a Rat Model of Partial Sciatic Nerve Ligation.Do the second-generation "atypical neuroleptics" have analgesic properties? A structured evidence-based review.Obsessive compulsive disorder and migraine: case report, diagnosis and therapeutic approach.New drugs for migraineConcomitant medication of psychoses in a lifetime perspective.Pharmacological management of mood and anxiety disorders in headache patients.Current trends in migraine prophylaxis.Advances in diagnostic and treatment options in patients with fibromyalgia syndromeThe Cyclic Vomiting Syndrome Threshold: A Framework for Understanding Pathogenesis and Predicting Successful TreatmentsHeadache as a presenting feature in patients with serotonin syndrome: a case series.Latin American consensus on guidelines for chronic migraine treatment.Improving acute pain management in emergency medicine.Headache research and medical practice in Brazil: an historical overview.Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration.Quetiapine for the prevention of migraine refractory to the combination of atenolol + nortriptyline + flunarizine: an open pilot study.An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine.Expert opinion: migraine, psychiatric comorbidities, and treatment.Effect of divalproex on metabolic parameters is dose related in migraine prophylaxis.Treatment of refractory chronic daily headache with the atypical antipsychotic ziprasidone--a case series.Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats.Migraine headache and bipolar disorder comorbidity: A systematic review of the literature and clinical implications.A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse
P2860
Q24188129-5EA4958C-8EA3-4524-8575-4E0FC21168EEQ24194323-AE8B97ED-E32A-4413-AEC3-BAE9C1873B86Q24199151-A922E64B-67EA-440A-946A-9B92E7F12025Q24201668-4B1DA18A-381F-4934-BCF3-7F49B5BD65CBQ24240928-F7C803A0-9BEA-4ECB-9B54-F35607035F53Q34412065-7423B0A0-BD83-43FA-9340-2C02B6035426Q35697916-DE18B51C-5930-496C-8753-1A07F83F3656Q35847279-51B24C03-FB04-4972-9465-431FE6D40C08Q35962645-CA073D30-2727-4464-992E-155AF62610D1Q36260635-DE6881BF-8BCF-4BFA-9ECC-EE14F2C03F7BQ36332611-E7B20628-D4B5-42CE-AD35-E6FFDB174F9EQ36420453-3E17E275-CB03-447F-B8E6-E45075054E70Q36620652-38DFBB66-F07A-491B-926E-9150C1B6F89AQ36787468-76DE5DAF-1AB7-49E5-9F3B-96C7C7BF7A95Q37358110-03334679-DA66-43AC-A34C-69E71BA24940Q37620335-B4000435-ACA2-471C-8B5E-AFF552DE2EB1Q38119391-27530AD4-EEBE-4BFF-8666-757F03EA1737Q38121835-81F47516-61C0-442F-BDAE-0092975BA326Q38317178-11A1BCF4-DBA5-4DAB-8243-66EF71542611Q38346851-E445ABD4-ED96-4B17-BE5F-18456FF3B7CAQ38749335-96EF86A2-6284-455B-8551-EEFFB787FE6DQ42601328-8D391E35-1878-4BBF-80B0-60AE65D50395Q42642430-93DFDE32-067B-46C9-8A89-9011AEE11530Q46524544-38E88C58-93F8-4D28-833F-9CF58287D072Q46657591-0AA055D7-1858-418D-B2AA-2AF7EB0FB153Q46702831-A64FCBB3-950E-4177-951B-B27889CDBC51Q47302385-C5D6C601-B0FF-4458-B96D-2DF4FA70B44FQ48059675-73313721-2269-43D0-AA48-77CD6566CDD5Q56997367-36C0CC82-4449-4402-8F8C-C60E2EF56942
P2860
Olanzapine in the treatment of refractory migraine and chronic daily headache.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Olanzapine in the treatment of refractory migraine and chronic daily headache.
@en
Olanzapine in the treatment of refractory migraine and chronic daily headache.
@nl
type
label
Olanzapine in the treatment of refractory migraine and chronic daily headache.
@en
Olanzapine in the treatment of refractory migraine and chronic daily headache.
@nl
prefLabel
Olanzapine in the treatment of refractory migraine and chronic daily headache.
@en
Olanzapine in the treatment of refractory migraine and chronic daily headache.
@nl
P2093
P2860
P1433
P1476
Olanzapine in the treatment of refractory migraine and chronic daily headache.
@en
P2093
Aaron L Shechter
Mario F P Peres
Mary M Hopkins
Todd D Rozen
William B Young
P2860
P304
P356
10.1046/J.1526-4610.2002.02126.X
P577
2002-06-01T00:00:00Z